经导管主动脉瓣置换术治疗左心室辅助装置患者症状性主动脉瓣反流的短期结果
该回顾性研究分析了2010年10月至2017年8月期间286例植入持久连续流左心室辅助装置(CF-LVAD)的终末期心衰患者,其中9例随后出现显著症状性主动脉瓣反流(AI)并接受经导管主动脉瓣置换术(TAVR)。所有9例患者TAVR术后AI均解决并出院回家,6个月时89%的患者在LVAD支持下存活,纽约心功能分级显著改善。结论认为TAVR是LVAD患者发生症状性AI的成功治疗方式。
要点
- CF-LVAD支持3年后近三分之一患者出现至少中度AI。
- 9例症状性AI患者接受TAVR后AI均解决并出院。
- 6个月时89%患者在LVAD支持下存活,心功能改善。
核心结论
- TAVR是LVAD患者发生症状性主动脉瓣反流的成功治疗方式。
研究设计与样本
- 回顾性病历审查与数据分析,时间范围为2010年10月至2017年8月。
- 共286例终末期心衰患者植入持久CF-LVAD,其中9例 subsequently 出现显著症状性AI并接受TAVR。
主要发现
- 所有9例患者均接受1次TAVR手术,AI均解决并出院回家。
- 手术并发症包括需置入第二个瓣膜稳定的瓣膜移位、腹膜后及腹股沟血肿、需凝血酶注射的假性动脉瘤。
- 从植入时至6个月纽约心功能分级显著改善。
- 2例患者在6个月内发生非计划心衰相关住院。
- 6个月时89%的患者在LVAD支持下存活。
临床怎么用
- 对于LVAD支持后出现症状性AI的患者,TAVR可作为治疗选择。
局限性
- 回顾性研究设计,样本量小(9例接受TAVR)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After 3 years of continuous-flow left ventricular assist device (CF-LVAD) support, nearly a third of patients develop at least moderate aortic insufficiency (AI). Percutaneous occluder devices, surgical aortic valve replacement (SAVR), and urgent heart transplantation are available treatment options. Transcatheter aortic valve replacement (TAVR) has not been widely used for treating symptomatic AI in patients on LVAD support. METHODS: Retrospective chart review and data analysis from October 2010 through August 2017 was performed. A total of 286 patients with end-stage heart failure (ESHF) were implanted with a durable CF-LVAD. Nine patients subsequently developed significant symptomatic AI, which was treated with TAVR. RESULTS: All 9 patients had 1 TAVR procedure with resolution of AI and were discharged home. Procedural complications include valve migration warranting a second valve for stabilization, retroperitoneal and groin hematoma, and pseudoaneurysm requiring thrombin injection. A significant improvement of the New York Heart Association classification was noted from the time of implant to 6 months. Two patients had unplanned heart failure‒related hospitalizations within 6 months. At 6 months, 89% of patients were alive on LVAD support. CONCLUSIONS: TAVR is a successful treatment modality for LVAD patients who develop symptomatic AI.
引用
- Yehya A, Rajagopal V, Meduri C, et al. Short-term results with transcatheter aortic valve replacement for treatment of left ventricular assist device patients with symptomatic aortic insufficiency. J Heart Lung Transplant. 2019. PMID: 30898555. doi:10.1016/j.healun.2019.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。